Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
ORIGINAL ARTICLE
Year : 2017  |  Volume : 30  |  Issue : 2  |  Page : 350-355

Hyoscine butylbromide for shortening of the first stage of labor in primigravid women


Department of Obstetrics and Gynecology, Faculty of Medicine, Menoufia University, Menoufia Governorate, Egypt

Date of Submission26-Jul-2016
Date of Acceptance06-Nov-2016
Date of Web Publication25-Sep-2017

Correspondence Address:
Hasnaa M Zidan
El Shohadaa City, Menoufia Governorate, 32841
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1110-2098.215455

Rights and Permissions
  Abstract 

Objectives
The aim of this work was to study the efficacy of hyoscine butylbromide(HBB) for shortening of the first stage of labor in primigravid women.
Background
Prolonged labor is one of the most important risk factors for perinatal compromise and, if caused by obstructed labor, it carries the risk for uterine rupture, postpartum hemorrhage, puerperal sepsis, and maternal death.
Patients and methods
The study was a randomized, double-blinded, controlled trial. One hundred and ten primigravid term pregnant women in spontaneous labor received either HBB or a placebo intramuscularly once the women entered the active phase of labor. The primary outcome measured was the duration of the first stage of labor. Secondary outcomes were the duration of the second and third stages of labor, blood loss at delivery, rate of cesarean section, and Apgar scores for the neonates.
Results
A total of 110 women yielded data for analysis. Of them, 55 women received HBB and 55 received placebo. The mean duration of the first stage in the study group was 208.16±17.24min, compared with 258.16±15.27min in the control group; there was a highly significant statistical difference(P=0.00). There were no significant changes in the duration of the second stages of labor(P=0.09). There were no significant changes in the duration of the third stages of labor (P=0.16). There were no significant statistical differences in blood loss or Apgar scores. There was no significant statistical difference in the cesarean section rate or instrumental delivery.
Conclusion
HBB is effective in significantly reducing the duration of the first stage of labor and is not associated with any apparent short-term adverse outcomes in the mother or neonate.

Keywords: augmentation, duration, first stage, hyoscine butylbromide, labor


How to cite this article:
Kandil MA, Sayyed TM, El-Mallah EM, Rezk MA, Zidan HM. Hyoscine butylbromide for shortening of the first stage of labor in primigravid women. Menoufia Med J 2017;30:350-5

How to cite this URL:
Kandil MA, Sayyed TM, El-Mallah EM, Rezk MA, Zidan HM. Hyoscine butylbromide for shortening of the first stage of labor in primigravid women. Menoufia Med J [serial online] 2017 [cited 2017 Oct 21];30:350-5. Available from: http://www.mmj.eg.net/text.asp?2017/30/2/350/215455


  Introduction Top


Dystocia remains the most common indication for emergency cesarean section in England and for primary cesarean section in the USA. As such, it is a major contributor to operative and instrumental intervention, especially in nulliparous women[1],[2]. This is a major clinical problem in modern obstetric practice and intrapartum care, causing substantial suffering to the mother and her offspring[3]. Factors influencing maternal and neonatal outcome of pregnancy have been considered by researchers. Duration of labor varies widely depending on demographic, clinical, and genetic factors, uterine activity, fetal lie or presentation, and number of fetuses[4].

The safety of active management of labor has been demonstrated by several prospective randomized clinical trials involving over3000 women. Ashorter duration of labor from admission to delivery has also been consistently reported in numerous studies of women treated with the active management protocol[5].

Hyoscine butylbromide(HBB) belongs to the parasympatholytic group of drugs and is a semisynthetic derivative of scopolamine. It is an effective antispasmodic drug without the untoward side effects of atropine. HBB acts primarily by blocking the transmission of neural impulses in the intraneural parasympathetic ganglia of abdominal organs, apparently inhibiting cholinergic transmission in the synapses of the abdominal and pelvic parasympathetic ganglia, thus relieving spasms in the smooth muscles of gastrointestinal, biliary, urinary tract, and female genital organs, especially the cervicouterine plexus, thus aiding cervical dilatation[6].

Spasmolytic drugs are frequently used in delivery rooms to overcome cervical spasms and thus reduce the duration of labor[7]. The anticholinergic spasmolytics have undesirable anticholinergic side effects. Hence, nonanticholinergic spasmolytics are preferred during pregnancy. Hyoscyamine when injected into humans during pregnancy has been reported to increase the fetal heartbeat. There have been several studies on different antispasmodic agents that shorten the first stage of labor[8]. Medical interventions related to prolonged time of delivery had increased during the last years, although perinatal results over the same period, particularly those of cerebral palsy. Initially, active management of labor was associated with a low cesarean section rate, in association with earlier interventions[9],[10].

Because some pregnant women prefer and require little or no medical intervention during labor, homebirth rates are rising slightly and many home-like birth centers have been established near conventional labor wards. Meta-analysis shows some benefits from home-like settings for childbirth, such as lower rates of intervention. Moreover, they are associated with higher levels of patient satisfaction with care[11]. The debate on the interventions associated with active management has focused on the cesarean section rates, but other considerations can be very important to individual women, who might, therefore, prefer acceleration for nonmedical reasons. It has been demonstrated that artificial rupture of membranes alone, when used systematically, leads to a significant and substantial diminution in the duration of labor[12].


  Patients and Methods Top


The study was conducted during the period from 2015 to 2016 at Menoufia University Hospitals(Egypt). The study protocol was approved by the local ethics committee of the Department of Obstetrics and Gynecology, Menoufia University. All participants provided written informed consent before inclusion into the study. The study involved 110 pregnant women.

Inclusion criteria were as follows: primigravid women aged 20years or older; singleton pregnancy presenting by the vertex; gestational age between 37 and 42weeks; and established, spontaneous labor with either intact membranes or spontaneous rupture of membranes for less than 12h(established labor is defined as the presence of regular two to three uterine contractions every 10min, associated with progressive cervical effacement and dilatation). Examination was carried out by the same examiner.

Exclusion criteria were as follows: previous uterine scarring, malpresentation, antepartum hemorrhage, multiparity, twin pregnancy, labor induction, prolonged premature rupture of membranes(>12h), epidural analgesia, contraindication to vaginal delivery, and contraindication to hyoscine.

All participants were subjected to full history taking and complete physical and obstetric examination including obstetric ultrasound. They were divided into two groups:

  • Group1(the study group), which included 55 pregnant women who received prefilled 2ml HBB (40mg) through intramuscular injection (IMI)
  • Group2(the control group), which included 55 pregnant women who received prefilled 2ml normal saline through IMI.


On admission, enrolled women were assigned to one of the described interventions according to a trial sequence, which was prepared using random number table in a statistical text book, and then the determined assignment sequence was hidden in sequentially numbered, opaque, sealed envelopes. The trial was double-blinded; the caregivers and the participants were blinded to the type of intervention. Apartogram was maintained throughout labor. Cardiotocography (CTG) was used to record fetal heart rate; augmentation with oxytocin was carried out if needed.

At the end of the study, the data collected were tabulated and analyzed using statistical package for the social science software (SPSS, IBM, Chicago, USA). The results were expressed by applying ranges, means±SD, the c2-test, t- test, and P values.


  Results Top


The study showed that there was no significant difference between the two groups as regards maternal age, BMI, gestational age, maternal disease, hemoglobin concentration, and occupation[Table1]. There was a highly significant statistical difference between the two groups as regards duration from admission until full cervical dilation, duration from admission until delivery, and rate of cervical dilation(P=0.00). However, there was no significant statistical difference between the two groups as regards augmentation of labor, duration of second stage of labor, duration of third stage of labor, and mode of delivery. No patients suffered from postpartum hemorrhage in both groups [Table2] and [Figure1]. There was no significant statistical difference between the two groups as regards the adverse effect of HBB[Table3] and [Figure2]. There was no significant statistical difference between the two groups as regards CTG changes, Apgar score at 1 and 5min, neonatal intensive care unit admission, and neonatal weight [Table4] and [Figure3].
Table1: Patient's characteristics

Click here to view
Table2: Labor dynamics

Click here to view
Table 3: Adverse effects of hyoscine butylbromide

Click here to view
Table 4: Fetal and neonatal outcomes

Click here to view
Figure 1: Labor dynamics.

Click here to view
Figure 2: Adverse effects of hyoscine butylbromide (HBB).

Click here to view
Figure 3: Neonatal outcome.

Click here to view



  Discussion Top


This randomized controlled study was conducted with an objective to evaluate the efficacy of HBB for shortening of the first stage of labor in primigravid women.

The reduction in first-stage duration may also prove to be of particular importance for women with a borderline placental reserve, oligohydramnios, or risk for prolonged variable deceleration during labor, as may be encountered in women with hypertension (both chronic and gestational) and in women with hemolytic anemia, which is quite common in Egyptian population. Prolonged labor in these women may result in the fetoplacental reserves becoming depleted, with consequent signs of fetal distress and an increased cesarean section rate [13].

In the present study, the mean duration from admission until full cervical dilatation was 208.16±17.24min in the study group compared with 258.16±15.27min in the control group. Thus, the duration from admission until full cervical dilatation was shortened by 50min.

In the study by Al Qahtani and Al Hajeri[13], the mean duration from admission until full cervical dilatation was 165±67.0min in the study group and 214±79.0min in the control group, with a difference of 50min in the study group.

In the study by Al Khishali etal. [14], the mean duration from admission until full cervical dilatation was 167.7±76.2min in the study group and 193.8±58.0min in the control group; thus, the duration from admission until full cervical dilatation was shortened by 26.1min.

However, in the study by Aziz[15], the mean duration from admission until full cervical dilatation was 205.8min in the study group and 270min in the control group; thus, the duration from admission until full cervical dilatation was shortened by 64.2min.

In the present study, the rate of cervical dilatation was 1.71±0.13cm/h in the study group and 1.05±0.06cm/h in the control group. However, in the study by Shwetha etal.[7], the mean cervical dilatation rate was 2.78±0.54cm/h in the study group and 1.97±0.28cm/h in the control group.

In the study by Edessy etal. [16], the mean cervical dilatation rate was 1.8±0.59cm/h in the study group and 0.98±0.55cm/h in the control group.

In another study by Aziz [15], the mean cervical dilatation rate was 2.04cm/h in the study group and 1.5cm/h in the control group.

In the present study, no significant difference was found as regards the duration of the second and third stages of labor, which was approved by Edessy etal. [16] and Al Khishali etal.[14].

In the present study, none of the patients reported postpartum complications. There was only one case in the study group in which delivery was through suction due to maternal distress. All other patients delivered vaginally. None of the studied patients delivered through cesarean section.

Ina study by Al Qahtani and Al Hajeri [13], instrumental vaginal delivery was performed in six women in the study group and in six women in the control group. However, delivery was performed through cesarean section in five women in the study group and in three women in the control group. Only two patients were complicated by vaginal tears reported in the study group. Thus, there was no significant statistical difference as regards mode of delivery and postpartum complications.

In the study by Shedid [17], two patients delivered through forceps, 13patients through suction, seven patients through cesarean section, and 53patients delivered through normal vaginal delivery (NVD) in the study group; in the control group, three patients delivered through forceps, 22patients through suction, 12patients through cesarean section, and 38patients through in the control group. Of the five patients who delivered through cesarean section in the control group, two patients were complicated by postpartum hemorrhage in the study group versus three cases in the control group. There was no significant statistical difference between the two groups as regards mode of delivery and postpartum complication.

In this study, there was no significant statistical difference as regards CTG changes, Apgar score, neonatal weight, and NICU admission. These results were approved in the study by Aziz [15] and Edessy etal. [16].


  Conclusion Top


On the basis of the results of the present study and noting the supportive data from similar clinical trials, HBB is effective in significantly reducing the duration of the first stage of labor and the need for further analgesia. Furthermore, it is not associated with any apparent short-term adverse outcomes in the mother or neonate.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

 
  References Top

1.
BraggF, CromwellDA, EdozienLC. Variation in rates of caesarean section among English NHS trusts after accounting for maternal and clinical risk: cross sectional study. BMJ 2010; 341:c5065.  Back to cited text no. 1
    
2.
BrennanDJ, RobsonMS, MurphyM, O'HerilyC. Comparative analysis of international caesarean delivery rates using 10-group classification identifies significant variation in spontaneous labour. Am J Obstet Gynecol 2009; 201:308. e1–308. e8.  Back to cited text no. 2
    
3.
MillenKR, KuaK, ZhaoL, GecsiK. Evidence-based guidelines in labor management. Obstet Gynecol Surv 2014; 69:209–217.  Back to cited text no. 3
    
4.
TerkawiAS, JacksonWM, ThietMP, HansotiS, TabassumR, FloodP. Oxytocin and catechol-O-methyltransferase receptor genotype predict the length of the first stage of labor. Am J Obstet Gynecol 2012; 207:184–188.  Back to cited text no. 4
    
5.
SadlerLC, DavisonT, MccowanLME. Arandomised controlled trial and meta-analysis of active management of labour. BJOG 2000; 107:909–915.  Back to cited text no. 5
    
6.
RohwerAC, KhondoweO, YoungT. Antispasmodics for labour. Cochrane Database Syst Rev 2012; 15:CD009243.  Back to cited text no. 6
    
7.
ShwethaBR, SubramanianS, SolankePV. Astudy of the effects of drotaverine hydrochloride and hyoscine butylbromide in the acceleration of the first stage of labour in primigravidae at SMIMS. JEvid Based Med Healthc 2016; 3:1166–1169.DOI: 10.18410/jebmh/2016/267.  Back to cited text no. 7
    
8.
TabassumS, AfridiB, AmanZ. Phloroglucinol for acceleration of labor: double blind randomized controlled trial. JPak Med Assoc 2005; 55:270–273.  Back to cited text no. 8
    
9.
VogelJP, SouzaJP, Gülmezoglu AM. Patterns and outcomes of induction of labour in Africa and Asia: a secondary analysis of the WHO Global Survey on Maternal and Neonatal Health. PLoS One 2013; 8:65612.  Back to cited text no. 9
    
10.
GoffientF, BreatG. Thefutureof labour management. In: ChamberlineG, SteerP, editors. Turnbull's obstet. 3rded. San Diego, California, USA: Harcourt Publishers Limited; 2001. 487–491.  Back to cited text no. 10
    
11.
HodnettE. Caregiver support for women during childbirth. Cochrane Database Syst Rev 2000; 2:CD000199.quoted from[10].  Back to cited text no. 11
    
12.
Fraser W Turcot L Krauss I Brisson-CarrolG. Amniotomv for shortening spontaneous labor, Cochrane review. Cochrane Database Syst Rev 2013; 18:CD006167.quoted from[10].  Back to cited text no. 12
    
13.
Al QahtaniNH, Al HajeriF. The effect of hyoscine butylbromide in shortening the first stage of labor: a double blind, randomized, controlled, clinical trial. Ther Clin Risk Manag 2011; 7:495–500.  Back to cited text no. 13
    
14.
Al-KhishaliWA, RasheedF, HussainS. The effect of 20mg hyoscine butylbromide on Normal Labor in Iraqi Primi-and Multi-gravida Women. JAdv Sci Res 2012; 3:70–73.  Back to cited text no. 14
    
15.
AzizM. Effect of rectal hyoscine butyl bromide suppositories on first stage of labor. Int J Adv Res 2014; 2:128–135.  Back to cited text no. 15
    
16.
EdessyM, EL-DarwishA, NasrA, AliA, TammamM. Different modalities in first stage enhancement of labor. General Health Med Sci 2015; 2:1–4.  Back to cited text no. 16
    
17.
ShedidAA. Rectal hyoscine-N-butylbromide safely accelerates progress of labor in primipara: a placebo-controlled study. JAm Sci 2012; 8:512–516.  Back to cited text no. 17
    


    Figures

  [Figure1], [Figure2], [Figure3]
 
 
    Tables

  [Table1], [Table2], [Table3], [Table4]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Patients and Methods
Results
Discussion
Conclusion
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed39    
    Printed0    
    Emailed0    
    PDF Downloaded13    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]